Blog Posts

Assessing The Value Of Wearables In Interventional Clinical Trials

Posted by | Fuld + Company

This assessment of Wearables in clinial trials was originally published in: Clinical Leader

Health-Wearable-Smart-Watch

Advancements in biosensor technology are becoming increasingly common in the consumer space, with wrists adorned with Fitbits or similar devices, clothing embedded with “intelligent” fibers, and personal safety devices seen in healthcare facilities across the nation. Our culture is increasingly accustomed to tracking health metrics through smartphones and simple recreational wearables. In the pharmaceutical space, we are now seeing where success in the consumer segment can translate to value-adds through wearables in clinical trials.

In traditional pharmaceutical interventional clinical trials, collection of data for primary and secondary endpoints (objective and/or subjective) must take place in a clinical setting to maximize quality control and meet FDA requirements. In some cases, the FDA allows secondary endpoint data to be collected remotely (usually in the home setting), often through questionnaires completed by patients and/or their caregivers. Such data are usually subjective and as such are typically not sufficient for primary endpoint analysis in interventional trials. Novel wearable biosensors change the calculus by creating the opportunity to collect objective data outside the clinic.

Fuld + Company’s Life Science Consulting practice spans pharmaceuticals, biotechnology, diagnostics, medical device, health IT, and healthcare payers and providers.

Tags: , , , , , ,

Related Resources

Read More

Vogue Business’s Winter 2021 Business Index – Redefining innovation: How top brands measure up

The Vogue Business Index Winter 2021 update is now available. Published quarterly, the index provides comprehensive intelligence on the world’s […]

Read More

Corporate Venture Capital News and Trends – January 2022

A roundup of the latest news and developments relating to Corporate Venture Capital (CVC). If you would like a PDF […]

Read More

5G News and Trends – January 2022

For the latest and most important 5G news and developments from November and December 2021 please see below for all […]

Subscribe to our mailing list for our latest updates: